Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary.

Elizabeth A StewartAndrea S LukesRoberta VenturellaYulan LiElke HunscheRachel B WagmanAyman Al-Hendy

Published in: Journal of comparative effectiveness research (2024)

Relugolix combination therapy may lessen distress associated with uterine fibroid symptoms and improve health-related quality of life related to uterine fibroids.

Keyphrases

combination therapy
autism spectrum disorder
pregnancy outcomes
pregnant women
depressive symptoms